These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35632716)

  • 1. A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization.
    Liu Y; Li L; Timani KA; He JJ
    Viruses; 2022 May; 14(5):. PubMed ID: 35632716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
    Nguyen HT; Falzarano D; Gerdts V; Liu Q
    J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
    Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
    J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.
    Wang B; Zhang C; Lei X; Ren L; Zhao Z; Wang J; Huang H
    Virol Sin; 2021 Oct; 36(5):890-900. PubMed ID: 33835389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo.
    Li Y; Tan X; Deng J; Liu X; Liu Q; Zhang Z; Huang X; Shen C; Xu K; Zhou L; Chen Y
    Virol Sin; 2024 Jun; 39(3):447-458. PubMed ID: 38548102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    He X; Quan S; Xu M; Rodriguez S; Goh SL; Wei J; Fridman A; Koeplinger KA; Carroll SS; Grobler JA; Espeseth AS; Olsen DB; Hazuda DJ; Wang D
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33766889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.
    Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG
    Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
    Luo Y; Yu F; Zhou M; Liu Y; Xia B; Zhang X; Liu J; Zhang J; Du Y; Li R; Wu L; Zhang X; Pan T; Guo D; Peng T; Zhang H
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 replicon for high-throughput antiviral screening.
    Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Takazawa S; Kotaki T; Nakamura S; Utsubo C; Kameoka M
    Virus Res; 2023 Sep; 334():199176. PubMed ID: 37473963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication.
    Leardkamolkarn V; Sirigulpanit W; Chotiwan N; Kumkate S; Huang CY
    Virus Res; 2012 Feb; 163(2):552-62. PubMed ID: 22197424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function.
    Wang JM; Wang LF; Shi ZL
    Biochem Biophys Res Commun; 2008 Sep; 374(1):138-42. PubMed ID: 18619943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.
    Yang P; Yang Y; Wu Y; Huang C; Ding Y; Wang X; Wang S
    J Virol Methods; 2021 Sep; 295():114221. PubMed ID: 34182038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus.
    Chiem K; Park JG; Morales Vasquez D; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; Ye C; Martinez-Sobrido L
    Microbiol Spectr; 2022 Oct; 10(5):e0237922. PubMed ID: 35980204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
    Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
    Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
    Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
    Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
    Zhang Y; Song W; Chen S; Yuan Z; Yi Z
    Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.